This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It plays a crucial role in the development of drugs targeting central nervous system disorders, particularly those involving neurotransmitter modulation. The compound’s structure, featuring a fluorophenyl group and a carbamate moiety, makes it valuable for designing molecules with enhanced binding affinity and selectivity for specific biological targets. Additionally, it is employed in research settings for studying enzyme inhibition and receptor interactions, contributing to the discovery of novel therapeutic agents. Its applications extend to the production of chiral compounds, where its stereochemistry is leveraged to achieve desired pharmacological effects.